Page 2 - Blue Water Vaccines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Blue Water Announces Acquisition of ENTADFI®, an FDA-Approved Benign Prostatic Hyperplasia Asset

Blue Water Announces Acquisition of ENTADFI®, an FDA-Approved Benign Prostatic Hyperplasia Asset
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesFrank jaegerJoseph hernandezMitchell steinerEli lillyBusiness developmentCompany to hosta conferenceCompany board of directorsCompany transformationVeru incUniversity of oxfordExchange commissionBroader pharmaceutical company spanning multiple sectorsCincinnati children hospital medical centerUt health science center san antonioBlue water vaccines inc

Veru (VERU) Sells ENTADFI to Blue Water Vaccines (BWV) for Up to $100M

Veru (VERU) Sells ENTADFI to Blue Water Vaccines (BWV) for Up to $100M
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mitchell steinerSamuel fischexecutiveHannah gendelmanagerEli lillyVeru incBlue water vaccines incExchange commissionCompany formWall streetBlue water vaccinesBlue waterChief executive officerFast trackAnimal rulesLooking statementsthePrivate securities litigation reform act

Veru Sells ENTADFI Business for $20 Million Plus up to an Additional $80 Million from Sales Milestones

20.04.2023 - MIAMI, FL, April 20, 2023 (GLOBE NEWSWIRE) - Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for oncology and SARS-CoV-2 and other viral ARDS-related diseases, today announced the sale of its ENTADFI . Seite 1

United statesMitchell steinerVeru incBlue water vaccines incBlue water vaccinesBlue waterChief executive

Blue Water Vaccines : Regulation FD Presentation - Form 8-K

Blue Water Vaccines Announces Signing of Sponsored Research Agreement with The University of Texas Health Science Center at San Antonio to Initiate Non-Human Primate Study for Live Attenuated,. | April 12, 2023

United statesJoseph hernandezBlue water vaccines incExchange commissionCincinnati children hospital medical centerUt health science center san antonioUniversity of oxfordResearch agreement theBlue water vaccines announces signingSponsored research agreementTexas health science centerSan antonioInitiate non human primate studyLive attenuatedOrally delivered chlamydiaWater vaccines

Blue Water Vaccines Announces Partnership with AbVacc for Joint Development of Novel Monkeypox and Marburg Vaccine Candidates

Blue Water Vaccines Announces Partnership with AbVacc for Joint Development of Novel Monkeypox and Marburg Vaccine Candidates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJoseph hernandezM javad amanCenters for diseaseUniversity of texas health san antonioUniversity of oxfordNational institute of allergyWorld health organizationAbvacc incDelaware corporationExchange commissionBlue water vaccines incBiotherapeutics incUt health san antonioCincinnati children hospital medical centerNovo holdings